Matorras R, Reque J A, Usandizaga J A, Minguez J A, Larrea J L, Núñez L
Gynecol Obstet Invest. 1985;19(1):21-31. doi: 10.1159/000299004.
We studied 59 pregnancies in 48 female carriers of prosthetic heart valves. In 44 pregnancies the mother had a metal valve mostly with coumarin therapy and in 15 a bioprosthesis usually without hematologic treatment. In the patients with metal prostheses we had the following maternal complications: 1 maternal death, 3 valve thromboses, 2 heart failures and 1 puerperal hemorrhage. There was also a significantly increased rate of preterm, low birth weight infants and intrauterine growth retardation. Concerning malformations we found only 2 cases of mild nasal hypoplasia. Regarding the complications of bioprosthesis, we had only 1 case of paroxysmal tachycardia and no fetal complications. Comparing the results we came to the conclusion that pregnancy is much better tolerated in patients with bioprostheses and that in patients with metal prostheses the risk is increased if the mother is older than 30 years, if time of replacement is more than 5 years or if there is a history of previous thromboembolism or gravidic heart failure.
我们研究了48名人工心脏瓣膜女性携带者的59次妊娠情况。44次妊娠中母亲植入的是金属瓣膜,大多接受香豆素治疗;15次妊娠中植入的是生物瓣膜,通常未进行血液学治疗。在植入金属瓣膜的患者中,出现了以下母体并发症:1例母体死亡、3例瓣膜血栓形成、2例心力衰竭和1例产后出血。早产、低体重儿和宫内生长受限的发生率也显著增加。关于畸形,仅发现2例轻度鼻发育不全。关于生物瓣膜的并发症,仅1例阵发性心动过速,无胎儿并发症。比较结果后我们得出结论,植入生物瓣膜的患者对妊娠的耐受性要好得多,而植入金属瓣膜的患者,如果母亲年龄超过30岁、置换时间超过5年,或有既往血栓栓塞或妊娠心力衰竭病史,风险会增加。